If you are looking for an AI stock that is more promising than NVAX but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 20 Best AI ...
NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the Company granted a non- qualified stock option and restricted stock units to ...
Shares of NVAX stock opened at $8.19 on Wednesday. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of -3.62, a P/E/G ratio of 63.06 and a beta of 2.14. Novavax has a 52 week ...
Novavax Inc. closed 66.14% below its 52-week high of $23.86, which the company reached on June 6th.
Bank of America Securities analyst Alec Stranahan reiterated a Hold rating on Novavax (NVAX – Research Report) today and set a price target of ...
The stock's fall snapped a two-day winning streak.
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. The average of price targets set by Wall Street analysts ...
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. The average of price targets set by Wall Street analysts ...